- $6.50bn
- $6.98bn
- $4.77bn
- 94
- 78
- 76
- 97
Annual income statement for Genpact, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,022 | 4,371 | 4,477 | 4,767 | 5,080 |
| Cost of Revenue | |||||
| Gross Profit | 1,432 | 1,536 | 1,571 | 1,690 | 1,831 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,513 | 3,869 | 3,846 | 4,065 | 4,330 |
| Operating Profit | 509 | 502 | 631 | 702 | 750 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 483 | 465 | 602 | 677 | 730 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 369 | 353 | 631 | 514 | 552 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 369 | 353 | 631 | 514 | 552 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 369 | 353 | 631 | 514 | 552 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.92 | 2.1 | 3.4 | 2.85 | 3.13 |
| Dividends per Share |